Should I Order This Test?

Psoriatic Arthritis Screening

Identify patients with psoriasis who may have undiagnosed psoriatic arthritis using the validated PEST questionnaire. Up to 30% of psoriasis patients develop PsA — most go undiagnosed for years. This tool flags patients who need rheumatology referral.

📋 PEST Questionnaire · Ibrahim et al. · Validated in dermatology + primary care
This tool is designed for patients with known or suspected psoriasis. PsA can precede skin disease in ~15% of cases — if joint symptoms suggest inflammatory arthritis without visible psoriasis, check for nail changes, scalp psoriasis, and family history before ruling it out.
Evidence Base — PEST Questionnaire
The Psoriasis Epidemiology Screening Tool (PEST) was developed and validated for use in primary care and dermatology to identify undiagnosed PsA in psoriasis patients. A score ≥3 indicates likely PsA and should prompt rheumatology referral.
~92%
Sensitivity (≥3)
~78%
Specificity (≥3)
~30%
Psoriasis patients with PsA
1
Psoriasis Confirmation
The PEST was developed for patients with psoriasis. Confirm before proceeding.
—
Does this patient have psoriasis?
Diagnosed by any clinician — includes plaque, guttate, nail-only, or scalp psoriasis
No
Yes
Psoriasis not confirmed. The PEST questionnaire is validated specifically for psoriasis patients. If the patient has unexplained inflammatory arthritis without psoriasis, consider the RA classifier or AxSpA tool instead. Note: PsA can precede psoriasis — if family history or nail pitting is present, rheumatology referral may still be appropriate.
2
PEST Questionnaire
Five validated questions — ask the patient directly or complete together. Each "Yes" = 1 point.
1
Have you ever had a swollen joint?
Not just pain — actual swelling, warmth, or visible puffiness around a joint
No
Yes
2
Has a doctor ever told you that you have arthritis?
Any prior arthritis diagnosis — including osteoarthritis, though inflammatory arthritis is more significant
No
Yes
3
Do your fingernails or toenails have pits or ridges?
Nail pitting (small depressions), onycholysis (separation), or oil-drop discoloration — check nails on exam
No
Yes
4
Have you had pain in your heel?
Plantar fasciitis or Achilles enthesitis — morning heel pain, worse with first steps, reflects entheseal inflammation
No
Yes
5
Have you had a finger or toe completely swollen and painful?
Dactylitis ("sausage digit") — diffuse swelling of an entire digit, not just one joint; highly specific for PsA
No
Yes

Nail pitting and dactylitis are the most specific features for PsA — dactylitis in particular is rarely caused by anything else. Always examine nails during the skin exam in psoriasis patients.

i
PsA Clinical Subtypes
PsA has five distinct patterns — recognizing them helps distinguish PsA from RA and OA in primary care.
SubtypePatternClues
Oligoarticular ≤4 joints, asymmetric Most common (~40%); large + small joints; asymmetric is key
Polyarticular ≥5 joints Can mimic seroronegative RA; check nails and skin carefully
DIP predominant Distal interphalangeal joints Often with nail disease; classic but only ~5–10% of PsA
Axial Spine and sacroiliac joints Inflammatory back pain + psoriasis; HLA-B27 often positive
Arthritis mutilans Severe destructive Rare but aggressive; "telescoping" of digits; requires urgent referral
Clinical Pearls
🔍
Always Examine the Nails
Nail pitting is present in ~80% of PsA patients but only ~30% of psoriasis patients without arthritis. Check all 20 nails — even subtle pitting counts.
🌭
Dactylitis Is Highly Specific
A sausage digit — entire finger or toe swollen — is one of the most specific signs for PsA. Patients often dismiss it as a "sprained finger." Ask directly.
📊
RF Is Usually Negative
PsA is seronegative (~95%). A negative RF does not exclude inflammatory arthritis in a psoriasis patient — it actually supports PsA over RA.
🦶
Enthesitis Is Underdiagnosed
Plantar fasciitis and Achilles pain in a psoriasis patient should raise PsA suspicion. Enthesitis is common in PsA and rare in RA.
PEST Score
0
out of 5
1
2
3
4
5
Score ≥3 = refer to rheumatology
Questions Answered Yes
Swollen joint○
Arthritis diagnosis○
Nail pitting○
Heel pain○
Dactylitis○
Recommendation
🩹
Confirm psoriasis diagnosis, then answer the five PEST questions.
— Psoriasis Not Confirmed
PEST not applicable
The PEST questionnaire requires psoriasis as a prerequisite. If inflammatory arthritis is suspected without psoriasis, use the RA or AxSpA tools. Toggle psoriasis above to continue.
🟢 PEST Negative
Low probability of PsA
Score <3 suggests PsA is less likely. Monitor at each dermatology or primary care visit — PsA can develop over time in psoriasis patients. Reassess if new joint symptoms emerge.
Consider at Annual Review
Re-screen with PEST annually Examine nails
🔴 PEST Positive
Psoriatic arthritis likely
Refer to rheumatology. A PEST score ≥3 in a psoriasis patient has ~92% sensitivity for PsA. Early treatment prevents joint damage — don't delay referral for lab results.
Recommended
Rheumatology referral ESR + CRP RF + Anti-CCP (expect negative) CBC / CMP X-ray affected joints
Note: A negative RF and anti-CCP in a patient with inflammatory arthritis + psoriasis supports PsA rather than excluding it.
PEST Questions
1Ever had a swollen joint?
2Doctor told you that you have arthritis?
3Nail pitting or ridging?
4Heel pain?
5Entire finger or toe swollen?
Each Yes = +1 point
0–2 Low probability  ·  ≥3 Refer to rheumatology

Frequently Asked Questions

Common questions clinicians and patients ask after using this tool — and after receiving these results.

What percentage of people with psoriasis develop psoriatic arthritis? ▼
Approximately 20–30% of people with psoriasis develop psoriatic arthritis at some point in their lifetime. The risk appears to be higher in patients with more severe skin disease, nail psoriasis, scalp psoriasis, and inverse (flexural) psoriasis. Interestingly, there is no strong correlation between skin severity and arthritis severity — patients with minimal skin involvement can have severe, destructive arthritis. The average time from skin to joint disease onset is approximately 10 years, but arthritis can precede skin disease in up to 15% of cases.
What joints does psoriatic arthritis affect? ▼
PsA has several distinct patterns of joint involvement. The most common forms include: oligoarthritis (asymmetric involvement of ≤4 joints, large and small), symmetric polyarthritis (resembles RA), and DIP joint predominant disease (affecting the last knuckle, often with nail disease). Dactylitis — diffuse swelling of an entire finger or toe — is highly characteristic and seen in about 30–40% of PsA patients. Axial disease (spine and sacroiliac joints) occurs in about 25% of patients. Enthesitis (inflammation at tendon insertions) is also a key feature, particularly at the Achilles and plantar fascia.
How is psoriatic arthritis different from rheumatoid arthritis? ▼
PsA and RA can look similar but have key distinguishing features. PsA typically: involves DIP joints (RA spares DIP), causes dactylitis ('sausage digits'), is associated with psoriasis and nail changes, and is usually RF and anti-CCP negative (seronegative). RA characteristically involves the wrists and MCPs symmetrically, is RF/anti-CCP positive in 70–80% of cases, and does not cause dactylitis. On X-ray, PsA causes a characteristic 'pencil-in-cup' deformity in severe cases, while RA causes periarticular erosions. Misdiagnosing PsA as seronegative RA is a common error.
What is nail psoriasis and why does it matter for arthritis? ▼
Nail psoriasis — including nail pitting, onycholysis (separation from the nail bed), oil-drop sign, and subungual hyperkeratosis — affects approximately 80% of psoriatic arthritis patients compared to 30% of psoriasis patients without arthritis. Nail involvement is one of the strongest predictors of PsA development in psoriasis patients. Clinically, it matters because the nail changes are visible clues that should prompt joint assessment in psoriasis patients. The nail is embryologically similar to enthesis tissue, explaining the link between nail and joint disease in PsA.
What does a positive PEST score mean? ▼
A PEST (Psoriasis Epidemiology Screening Tool) score of 3 or more indicates a positive screen for psoriatic arthritis and warrants referral to rheumatology for formal assessment. The PEST questionnaire has a sensitivity of approximately 92% and specificity of 78% for identifying PsA among psoriasis patients in dermatology settings. A positive PEST does not diagnose PsA — that requires clinical examination and potentially imaging. A negative PEST (score 0–2) makes clinically significant PsA unlikely, though patients should still be monitored given the 30% lifetime risk.
Is there a blood test for psoriatic arthritis? ▼
There is no single definitive blood test for psoriatic arthritis. RF and anti-CCP are negative in most PsA patients (their presence suggests RA rather than PsA). ANA is positive in a minority. Inflammatory markers (CRP, ESR) can be elevated but are normal in up to 40% of patients. HLA-B27 is positive in approximately 20–25% of PsA patients (versus 85–90% in axial SpA). PsA is primarily a clinical diagnosis based on the pattern of joint involvement, presence of psoriasis or nail disease, and imaging findings. X-ray and MRI are used to confirm and characterize joint damage.
References
  1. Ibrahim GH, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27(3):469–474.
  2. Coates LC, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016;68(5):1060–1071.
  3. Taylor W, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–2673.
  4. Mease PJ, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–735.